(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Carnival Plc, Carnival, and FuelCell Energy.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Carnival Plc (CUK) | 13.09 | 12.84% | 2023-06-12 13:35:32 |
| 2 | Carnival (CCL) | 14.68 | 12.15% | 2023-06-12 10:39:07 |
| 3 | FuelCell Energy (FCEL) | 2.59 | 11.16% | 2023-06-12 13:09:38 |
| 4 | Plug Power (PLUG) | 10.19 | 11.12% | 2023-06-12 13:28:44 |
| 5 | Evoke Pharma (EVOK) | 1.62 | 9.46% | 2023-06-12 15:47:08 |
| 6 | Nio (NIO) | 8.40 | 8.73% | 2023-06-12 10:43:12 |
| 7 | Nikola (NKLA) | 0.76 | 8.35% | 2023-06-12 13:32:05 |
| 8 | Catalent (CTLT) | 41.97 | 8.14% | 2023-06-12 13:35:29 |
| 9 | Sabre Corporation (SABR) | 3.59 | 7.66% | 2023-06-12 13:29:12 |
| 10 | Peloton (PTON) | 8.94 | 7.52% | 2023-06-12 13:32:22 |
The three biggest losers today are Comtech Telecommunications Corp., Nasdaq Inc, and Evolving Systems.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Comtech Telecommunications Corp. (CMTL) | 9.38 | -17.14% | 2023-06-11 22:23:08 |
| 2 | Nasdaq Inc (NDAQ) | 51.67 | -10.64% | 2023-06-12 13:28:12 |
| 3 | Evolving Systems (EVOL) | 0.76 | -10.59% | 2023-06-12 15:48:09 |
| 4 | ClearSign Technologies Corporation (CLIR) | 1.24 | -8.82% | 2023-06-11 21:06:09 |
| 5 | Escalon Medical Corp. (ESMC) | 0.23 | -7.5% | 2023-06-12 15:12:07 |
| 6 | ClearOne (CLRO) | 0.92 | -7.17% | 2023-06-11 21:09:08 |
| 7 | Cumulus Media (CMLS) | 3.28 | -6.82% | 2023-06-11 21:15:07 |
| 8 | Inovio Pharmaceuticals (INO) | 0.49 | -6.6% | 2023-06-12 13:11:07 |
| 9 | ENGlobal Corporation (ENG) | 0.48 | -6.39% | 2023-06-12 13:15:08 |
| 10 | Cyclacel Pharmaceuticals (CYCCP) | 10.50 | -6.33% | 2023-06-12 05:07:07 |
Winners today
1. Carnival Plc (CUK) – 12.84%
Carnival Corporation & plc engages in the provision of leisure travel services. The company operates a fleet of more than 90 ships visit approximately 700 ports under AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, Princess Cruises, P&O Cruises (Australia), P&O Cruises (UK), and Seabourn brand names. It also provides port destinations and other services, as well as owns and owns and operates hotels, lodges, glass-domed railcars, and motorcoaches. The company sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. It operates in the United States, Canada, Continental Europe, the United Kingdom, Australia, New Zealand, Asia, and internationally. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.
NYSE ended the session with Carnival Plc jumping 12.84% to $13.09 on Monday, after two successive sessions in a row of gains. NYSE rose 0.31% to $15,547.54, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Carnival Plc has a trailing twelve months EPS of $-4.06.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.4%.
More news about Carnival Plc.
2. Carnival (CCL) – 12.15%
Carnival Corporation & plc engages in the provision of leisure travel services. The company operates a fleet of more than 90 ships visit approximately 700 ports under AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, Princess Cruises, P&O Cruises (Australia), P&O Cruises (UK), and Seabourn brand names. It also provides port destinations and other services, as well as owns and owns and operates hotels, lodges, glass-domed railcars, and motorcoaches. The company sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. It operates in the United States, Canada, Continental Europe, the United Kingdom, Australia, New Zealand, Asia, and internationally. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.
NYSE ended the session with Carnival jumping 12.15% to $14.68 on Monday, following the last session’s upward trend. NYSE jumped 0.31% to $15,547.54, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Carnival has a trailing twelve months EPS of $-4.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Carnival’s EBITDA is 104.03.
Revenue Growth
Year-on-year quarterly revenue growth grew by 173.1%, now sitting on 14.98B for the twelve trailing months.
More news about Carnival.
3. FuelCell Energy (FCEL) – 11.16%
FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.
NASDAQ ended the session with FuelCell Energy jumping 11.16% to $2.59 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.31.
Moving Average
FuelCell Energy’s value is way above its 50-day moving average of $2.26 and way under its 200-day moving average of $3.10.
Volume
Today’s last reported volume for FuelCell Energy is 21634100 which is 92.77% above its average volume of 11222700.
More news about FuelCell Energy.
4. Plug Power (PLUG) – 11.12%
Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.
NASDAQ ended the session with Plug Power rising 11.12% to $10.19 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Plug Power has a trailing twelve months EPS of $-1.4.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.43%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Plug Power’s EBITDA is 6.21.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 20% and 43.3%, respectively.
Moving Average
Plug Power’s value is way higher than its 50-day moving average of $8.94 and way under its 200-day moving average of $15.15.
Volume
Today’s last reported volume for Plug Power is 28852600 which is 27.52% above its average volume of 22625500.
More news about Plug Power.
5. Evoke Pharma (EVOK) – 9.46%
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
NASDAQ ended the session with Evoke Pharma rising 9.46% to $1.62 on Monday while NASDAQ jumped 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Evoke Pharma has a trailing twelve months EPS of $-2.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -408.53%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 2.8% and positive 11.7% for the next.
Yearly Top and Bottom Value
Evoke Pharma’s stock is valued at $1.62 at 17:32 EST, way under its 52-week high of $5.96 and way above its 52-week low of $1.37.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.7%, now sitting on 2.9M for the twelve trailing months.
More news about Evoke Pharma.
6. Nio (NIO) – 8.73%
NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.
NYSE ended the session with Nio rising 8.73% to $8.40 on Monday while NYSE rose 0.31% to $15,547.54.
Earnings Per Share
As for profitability, Nio has a trailing twelve months EPS of $-1.25.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nio’s EBITDA is -2.95.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nio’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Nio is 61438000 which is 30.27% above its average volume of 47161900.
Moving Average
Nio’s worth is above its 50-day moving average of $8.36 and way below its 200-day moving average of $11.35.
More news about Nio.
7. Nikola (NKLA) – 8.35%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola jumping 8.35% to $0.76 on Monday while NASDAQ jumped 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-2.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -137.05%.
Volatility
Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a positive 6.35%, a negative 0.55%, and a positive 6.03%.
Nikola’s highest amplitude of average volatility was 7.63% (last week), 5.84% (last month), and 6.03% (last quarter).
Sales Growth
Nikola’s sales growth is negative 16.8% for the present quarter and 37.9% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikola’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nikola’s EBITDA is 12.2.
More news about Nikola.
8. Catalent (CTLT) – 8.14%
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
NYSE ended the session with Catalent rising 8.14% to $41.97 on Monday, after four consecutive sessions in a row of losses. NYSE jumped 0.31% to $15,547.54, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Catalent has a trailing twelve months EPS of $2.29.
PE Ratio
Catalent has a trailing twelve months price to earnings ratio of 18.33. Meaning, the purchaser of the share is investing $18.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.73%.
Moving Average
Catalent’s value is below its 50-day moving average of $44.98 and way under its 200-day moving average of $58.70.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Catalent’s EBITDA is 45.35.
Yearly Top and Bottom Value
Catalent’s stock is valued at $41.97 at 17:32 EST, way under its 52-week high of $115.33 and way above its 52-week low of $31.45.
Volume
Today’s last reported volume for Catalent is 7386020 which is 62.37% above its average volume of 4548660.
More news about Catalent.
9. Sabre Corporation (SABR) – 7.66%
Sabre Corporation, through its subsidiaries, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation jumping 7.66% to $3.59 on Monday while NASDAQ jumped 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.85.
More news about Sabre Corporation.
10. Peloton (PTON) – 7.52%
Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, and Peloton Tread+ names. It also provides connected fitness subscriptions for various household users, and access to various live and on-demand classes, as well as Peloton Digital app for connected fitness subscribers to provide access to its classes. As of June 30, 2022, it had approximately 6.9 million members. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.
NASDAQ ended the session with Peloton jumping 7.52% to $8.94 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Peloton has a trailing twelve months EPS of $-6.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -279.85%.
More news about Peloton.
Losers Today
1. Comtech Telecommunications Corp. (CMTL) – -17.14%
Comtech Telecommunications Corp., together with its subsidiaries, designs, develops, produces, and markets products, systems, and services for communications solutions in the United States and internationally. It operates in two segments, Commercial Solutions and Government Solutions. The Commercial Solutions segment offers satellite ground station technologies, including single channel per carrier and time division multiple access modems, amplifiers, frequency converters, and network software to modulate, demodulate, and amplify signals, as well as to carry voice, video, and/or data over networks; and public safety and location technologies, such as 911 call handling and mapping solutions that allow cellular carriers and voice over the Internet carriers to deliver emergency calls to public safety emergency call centers. The Government Solutions segment provides tactical satellite-based networks, such as satellite modems, ruggedized routers, and solid-state drives; sustainment services for the secret Internet Protocol router and non-classified Internet Protocol router access point; and small aperture terminals. This segment also offers high-performance transmission technologies that are used in communication systems comprising electronic warfare, radar, and identification friend or foe (IFF); troposcatter technologies for satellite communication; and high-power radio frequency microwave amplifiers and related switching control technologies that are used in electronic warfare, communications, radar, IFF, and medical applications. The company serves satellite systems integrators, wireless and other communication service providers, satellite broadcasters, prime contractors and system suppliers, medical equipment companies, aviation industry system integrators, oil companies, and domestic and international defense and government customers, as well as end-customers. Comtech Telecommunications Corp. was founded in 1967 and is headquartered in Melville, New York.
NASDAQ ended the session with Comtech Telecommunications Corp. sliding 17.14% to $9.38 on Monday, after two consecutive sessions in a row of losses. NASDAQ rose 1.53% to $13,461.92, after two successive sessions in a row of gains, on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, Comtech Telecommunications Corp. has a trailing twelve months EPS of $-1.28.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 16, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 4.26%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Comtech Telecommunications Corp.’s EBITDA is 1.06.
Sales Growth
Comtech Telecommunications Corp.’s sales growth for the current quarter is 8.9%.
More news about Comtech Telecommunications Corp..
2. Nasdaq Inc (NDAQ) – -10.64%
Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. It operates in three segments: Market Platforms, Capital Access Platforms, and Anti-Financial Crime. The Market Platforms segment trading services, including equity derivative trading and clearing, cash equity trading, fixed income and commodities trading and clearing, and trade management service businesses. This segment operates various exchanges and other marketplace facilities across various asset classes, which include derivatives, commodities, cash equity, debt, structured products, and exchange traded products; and provides broker, clearing, settlement, and central depository services. This segment also handles assets, such as cash equities, equity derivatives, currencies, interest-bearing securities, commodities, energy products, and digital currencies. The Capital Access Platforms segment sells and distributes historical and real-time market data; develops and licenses Nasdaq-branded indexes and financial products; operates listing platforms; investment insights and workflow solutions; and offers investor relations intelligence, ESG solutions, and governance solutions. The Anti-Financial Crime segment includes anti financial crime management solutions, which offers Nasdaq Trade Surveillance, a SaaS solution for brokers and other market participants to assist them in complying with market rules, regulations, and internal market surveillance policies; Nasdaq Market Surveillance, a market surveillance solution for markets and regulators; and Verafin, a SaaS technology provider of anti-financial crime management solutions. The company was formerly known as The NASDAQ OMX Group, Inc. and changed its name to Nasdaq, Inc. in September 2015. Nasdaq, Inc. was founded in 1971 and is headquartered in New York, New York.
NASDAQ ended the session with Nasdaq Inc falling 10.64% to $51.67 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Nasdaq Inc has a trailing twelve months EPS of $2.3.
PE Ratio
Nasdaq Inc has a trailing twelve months price to earnings ratio of 22.47. Meaning, the purchaser of the share is investing $22.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.7%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 6.22B for the twelve trailing months.
Volume
Today’s last reported volume for Nasdaq Inc is 11398800 which is 337.72% above its average volume of 2604080.
Sales Growth
Nasdaq Inc’s sales growth is 2.8% for the present quarter and 4.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nasdaq Inc’s EBITDA is 5.36.
More news about Nasdaq Inc.
3. Evolving Systems (EVOL) – -10.59%
Symbolic Logic, Inc., a research and development organization, focuses on developing proprietary algorithms that model and predict behaviour of dynamic systems. It is also developing a set of tools and technologies for applying symbolic content to physical objects to catalog to track real-world objects. The company was formerly known as Evolving Systems, Inc. and changed its name to Symbolic Logic, Inc. in April 2022. The company was founded in 1985 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Evolving Systems falling 10.59% to $0.76 on Monday, after five consecutive sessions in a row of losses. NASDAQ jumped 1.53% to $13,461.92, after two consecutive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Evolving Systems has a trailing twelve months EPS of $-0.37.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.5%.
Volume
Today’s last reported volume for Evolving Systems is 33423 which is 1145.27% above its average volume of 2684.
More news about Evolving Systems.
4. ClearSign Technologies Corporation (CLIR) – -8.82%
ClearSign Technologies Corporation designs and develops products and technologies to enhance operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States and the People's Republic of China. Its ClearSign Core Burner Technology consists of an industrial burner body and a downstream porous ceramic structure or metal flame stabilizing device; ClearSign Core Plug & Play technology provides direct burner replacement for traditional refinery process heaters; and ClearSign Eye Flame Sensor, an electrical flame sensor for industrial applications. The company also provides ClearSign Core Boiler Burner; and ClearSign Core Flaring Burners technologies. It serves energy, institutional, commercial and industrial boiler, chemical, and petrochemical industries. The company was formerly known as ClearSign Combustion Corporation and changed its name ClearSign Technologies Corporation in November 2019. ClearSign Technologies Corporation was incorporated in 2008 and is headquartered in Tulsa, Oklahoma.
NASDAQ ended the session with ClearSign Technologies Corporation falling 8.82% to $1.24 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, ClearSign Technologies Corporation has a trailing twelve months EPS of $-0.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -70.55%.
Yearly Top and Bottom Value
ClearSign Technologies Corporation’s stock is valued at $1.24 at 17:32 EST, way below its 52-week high of $1.75 and way above its 52-week low of $0.50.
More news about ClearSign Technologies Corporation.
5. Escalon Medical Corp. (ESMC) – -7.5%
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.
NASDAQ ended the session with Escalon Medical Corp. falling 7.5% to $0.23 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Escalon Medical Corp. has a trailing twelve months EPS of $0.02.
PE Ratio
Escalon Medical Corp. has a trailing twelve months price to earnings ratio of 11.56. Meaning, the purchaser of the share is investing $11.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.5%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Escalon Medical Corp.’s EBITDA is 0.24.
Yearly Top and Bottom Value
Escalon Medical Corp.’s stock is valued at $0.23 at 17:32 EST, way under its 52-week high of $0.29 and way higher than its 52-week low of $0.05.
More news about Escalon Medical Corp..
6. ClearOne (CLRO) – -7.17%
ClearOne, Inc., together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices. It also provides video products, such as video conferencing and collaboration solutions; and AV networking, which deliver the IP A/V experience by streaming time sensitive high definition audio and video, and control over TCP/IP networks. In addition, the company offers professional microphones consisting of beamforming microphones, ceiling microphones, and wireless microphones. ClearOne, Inc. sells its commercial products to a network of independent professional audiovisual, information technology, and telecommunications distributors, as well as systems integrators, dealers, value-added resellers, and end-users. The company was incorporated in 1983 and is headquartered in Salt Lake City, Utah.
NASDAQ ended the session with ClearOne falling 7.17% to $0.92 on Monday, after five sequential sessions in a row of losses. NASDAQ rose 1.53% to $13,461.92, after two sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, ClearOne has a trailing twelve months EPS of $0.79.
PE Ratio
ClearOne has a trailing twelve months price to earnings ratio of 1.16. Meaning, the purchaser of the share is investing $1.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.74%.
Sales Growth
ClearOne’s sales growth is negative 36.7% for the current quarter and negative 22.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 44.6%, now sitting on 21.84M for the twelve trailing months.
More news about ClearOne.
7. Cumulus Media (CMLS) – -6.82%
Cumulus Media Inc., an audio-first media company, owns and operates radio stations in the United States. It owns and operates 406 stations in 86 markets, as well as approximately 9,500 affiliated stations through Westwood One. The company's content portfolio includes sports, news, talk, and entertainment programming from various brands, including the NFL, the NCAA, the Masters, CNN, the AP, the Academy of Country Music Awards, and other partners. It also provides digital marketing services, such as email marketing, geo-targeted display and video solutions, website and microsite building, hosting, social media management, reputation management, and search engine marketing and optimization. The company serves advertisers through broadcast and on-demand digital, mobile, social, and voice-activated platforms. Cumulus Media Inc. was incorporated in 2002 and is based in Atlanta, Georgia.
NASDAQ ended the session with Cumulus Media dropping 6.82% to $3.28 on Monday, after two successive sessions in a row of losses. NASDAQ rose 1.53% to $13,461.92, after two successive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Cumulus Media has a trailing twelve months EPS of $-0.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.08%.
Yearly Top and Bottom Value
Cumulus Media’s stock is valued at $3.28 at 17:32 EST, way under its 52-week high of $11.31 and way higher than its 52-week low of $2.57.
Moving Average
Cumulus Media’s value is under its 50-day moving average of $3.36 and way under its 200-day moving average of $5.98.
More news about Cumulus Media.
8. Inovio Pharmaceuticals (INO) – -6.6%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
NASDAQ ended the session with Inovio Pharmaceuticals sliding 6.6% to $0.49 on Monday, after two sequential sessions in a row of losses. NASDAQ rose 1.53% to $13,461.92, after two successive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.87.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 42.3%, now sitting on 10.18M for the twelve trailing months.
More news about Inovio Pharmaceuticals.
9. ENGlobal Corporation (ENG) – -6.39%
ENGlobal Corporation provides engineering and professional project execution services primarily to the energy sector in the United States and internationally. It operates through two segments, Commercial and Government Services. The Commercial segment provides multi-disciplined engineering services relating to the development, management, and execution of projects requiring professional engineering and related project management services. It offers conceptual studies, project definition, cost estimating, engineering design, environmental compliance, material procurement, project management, construction management, and fabrication services. The Government segment provides design, integration and implementation of process distributed control and analyzer systems, advanced automated data gathering systems, information technology, and the maintenance of these systems; automated fuel handling systems and maintenance services to military and public sector entities, government agencies, refineries, petrochemical, and process industry; and electrical and instrument installation, technical services, ongoing maintenance, calibration, and repair services. The company serves Fortune 500 companies in the energy industry and the United States government. ENGlobal Corporation company was founded in 1985 and is headquartered in Houston, Texas.
NASDAQ ended the session with ENGlobal Corporation sliding 6.39% to $0.48 on Monday, following the last session’s downward trend. NASDAQ rose 1.53% to $13,461.92, after two successive sessions in a row of gains, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, ENGlobal Corporation has a trailing twelve months EPS of $-0.58.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -134.34%.
Sales Growth
ENGlobal Corporation’s sales growth for the current quarter is 20.8%.
Volume
Today’s last reported volume for ENGlobal Corporation is 307681 which is 6.06% below its average volume of 327553.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ENGlobal Corporation’s EBITDA is 0.6.
Yearly Top and Bottom Value
ENGlobal Corporation’s stock is valued at $0.48 at 17:32 EST, way below its 52-week high of $2.24 and way higher than its 52-week low of $0.30.
More news about ENGlobal Corporation.
10. Cyclacel Pharmaceuticals (CYCCP) – -6.33%
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise Sapacitabine, an orally available prodrug of CNDAC, which is a novel nucleoside analog. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
NASDAQ ended the session with Cyclacel Pharmaceuticals falling 6.33% to $10.50 on Monday while NASDAQ rose 1.53% to $13,461.92.
Earnings Per Share
As for profitability, Cyclacel Pharmaceuticals has a trailing twelve months EPS of $-2.05.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -105.12%.
More news about Cyclacel Pharmaceuticals.
Stay up to date with our winners and losers daily report
